Mar. 12, 2022

AZD7648

oral DNA-PK inhibitor Ph. I/II candidate for advanced tumors from screening for selectivity vs. PI3Ka Mol. Cancer Ther. AstraZeneca

drughunter.com
Drug Hunter Team
Loading...

twitterlinkedinemail

Other molecules you may be interested in